BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 15319774)

  • 1. Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors.
    Shier LR; Schultz KR; Imren S; Regan J; Issekutz A; Sadek I; Gilman A; Luo Z; Panzarella T; Eaves CJ; Couban S
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):624-34. PubMed ID: 15319774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
    Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of peripheral blood CD34+ progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor.
    Teofili L; Iovino MS; Sica S; Pierelli L; Menichella G; De Stefano V; Rumi C; Leone G
    Exp Hematol; 1994 Sep; 22(10):990-5. PubMed ID: 7522187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of short-term administration of G-CSF (filgrastim) on bone marrow progenitor cells: analysis of serial marrow samples from normal donors.
    Martínez C; Urbano-Ispizua A; Rozman M; Rovira M; Marín P; Montfort N; Carreras E; Montserrat E
    Bone Marrow Transplant; 1999 Jan; 23(1):15-9. PubMed ID: 10037045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of differentiation antigens and adhesion molecules on CD34+ cells in peripheral blood and bone marrow after chemotherapy followed by administration of granulocyte colony stimulating factor.
    Masauzi N
    Hokkaido Igaku Zasshi; 1996 Nov; 71(6):771-83. PubMed ID: 8996844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
    Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
    Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
    Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
    Kiss J; Kunstár A; Fajka-Boja R; Dudics V; Tóvári J; Légrádi A; Monostori E; Uher F
    Exp Hematol; 2007 Feb; 35(2):305-13. PubMed ID: 17258079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization.
    Jin F; Zhai Q; Qiu L; Meng H; Zou D; Wang Y; Li Q; Yu Z; Han J; Li Q; Zhou B
    Bone Marrow Transplant; 2008 Nov; 42(9):581-8. PubMed ID: 18679363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.
    Yannaki E; Athanasiou E; Xagorari A; Constantinou V; Batsis I; Kaloyannidis P; Proya E; Anagnostopoulos A; Fassas A
    Exp Hematol; 2005 Jan; 33(1):108-19. PubMed ID: 15661404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.
    Gaia S; Smedile A; Omedè P; Olivero A; Sanavio F; Balzola F; Ottobrelli A; Abate ML; Marzano A; Rizzetto M; Tarella C
    J Hepatol; 2006 Jul; 45(1):13-9. PubMed ID: 16635534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions.
    Huang XJ; Chang YJ; Zhao XY
    Transpl Immunol; 2007 Apr; 17(3):193-7. PubMed ID: 17331846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of stromal cell-derived factor and its receptor-CXCR4 in G-CSF-induced hematopoietic stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):98-102. PubMed ID: 17650669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.